SGH
CGON icon

Sivik Global Healthcare’s CG Oncology CGON Stock Holding History

Sivik Global Healthcare’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,000
Closed -$1.45M – 39
2025
Q4 		$1.45M Buy
+35,000
New +$1.45M 0.42% 47

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sivik Global Healthcare's CGON Position: Q1 2026 in Review

Sivik Global Healthcare sold out of CG Oncology (CGON) in Q1 2026, closing a stake of 35,000 shares — an estimated $1.45M sold.

Sivik Global Healthcare first reported a position in CGON in Q4 2025 and held it in 1 quarter. The position peaked at $1.45M in Q4 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Sivik Global Healthcare reported no remaining CG Oncology position as of Q1 2026 after selling out during the quarter.
  • Sivik Global Healthcare sold 35,000 CG Oncology shares in Q1 2026, an estimated $1.45M.
  • Sivik Global Healthcare first reported a position in CG Oncology in Q4 2025 and held it in 1 quarter.
  • Sivik Global Healthcare's CG Oncology position peaked at $1.45M in Q4 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Sivik Global Healthcare's 13F filing for Q1 2026, filed 15 Apr 2026.